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ABSTRACT
Introduction: Obesity is associated with the development of metabolic disorders that 
can be diagnosed through inflammatory and oxidative biomarkers.
Background: This study evaluated the influence of obesity and overweight on serum 
concentrations of vitamins C and E, transforming growth factor beta 1 (TGF-β1) and 
cardiometabolic parameters.
Methods: A cross-sectional study was conducted with 169 participants (24 normal 
weight, 16 overweight and 129 obese). Anthropometric measures and concentrations 
of vitamins C and E, thiobarbituric acid reactive substances (TBARS), TGF-β1, lipid 
profile, glycated hemoglobin (HbA1c), glucose and insulin were determined, and 
homeostatic model assessment of insulin resistance (HOMA-IR) and insulin sensitivity 
(IS) were calculated.
Results: Obese and overweight participants showed significantly higher levels of 
TGF-β1, vitamin E, insulin, HbA1c, glucose, cholesterol, low-density lipoprotein 
cholesterol (LDL-c), triglycerides, HOMA-IR, and TBARS compared with normal 
weight patients, associated with a significant reduction in IS, high-density lipoprotein 
cholesterol (HDL-c), and vitamin C.
Conclusions: Obesity and overweight may lead to significant changes in TGF-B1, 
biochemical and oxidative markers. Increased levels of TGF-β1 may promote 
inflammation and interfere with IS. Reduced concentrations of vitamin C and increased 
levels of TBARS led to a redox imbalance in obese and overweight patients, suggesting 
that vitamin E is not a promising oxidative biomarker since it is lipophilic and its 
concentration is influenced by body fat. These results may help determine the oxidative 
and inflammatory pathways related to obesity and its comorbidities.
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Obesity has increased substantially worldwide in recent years and in all 
age groups, being thus considered a public health problem. The disease is 
characterized by the deposition of abnormal or excessive fat in adipose tissue, 
which must be prevented, mainly for being associated with chronic conditions, 
such as cardiovascular diseases, dyslipidemia, systemic hypertension, insulin 
resistance (IR), type 2 diabetes mellitus (DM2) and some types of malignant 
neoplasms1.
Evidence has placed obesity as a chronic subclinical inflammatory condition, 
associated with dysfunction of the immune system and increase in oxidative 
stress2. A reduction in antioxidant defense systems, or an increased generation 
of oxidative stress, whether radical or not, may result in oxidative damage in 
macromolecules of various cellular structures, which, if left unrepaired, will 
affect the functionality of cells, tissues and organs3.
Recent evidence indicates that reactive oxygen species (ROS) could modulate 
transforming growth factor beta (TGF-β) signaling through different pathways, 
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including the Smad pathway. TGF-β1 increases 
the production of ROS and suppresses antioxidant 
enzymes, leading to a redox imbalance, while ROS, 
in turn, induce/activate TGF-β14. TGF-β1 increases 
the production of ROS by impairing mitochondrial 
function and inducing NADPH oxidases (NOXs), 
especially NOX45. TGF-β1 also suppresses antioxidant 
defense, including the synthesis of glutathione, the 
most abundant intracellular free thiol, and several 
other antioxidant enzymes, leading to oxidative stress6.
One of the ways through which the body neutralizes 
free radicals is using dietary antioxidants such as 
α-tocopherol (vitamin E), ascorbic acid (vitamin C), 
β-carotene (vitamin A) and phenolic compounds with 
a predominance of flavonoids and polyflavonoids7. 
Dietary antioxidants inactivate oxidative substances 
more rapidly in obese than in non-obese individuals. 
This occurs because the amount of oxidants in obese 
individuals is higher, with greater need for antioxidants 
to avoid possible damage8.
Vitamins C and E play an important physiological 
role in the reduction of oxidative stress. Vitamin C is a 
water-soluble antioxidant which neutralizes free radicals, 
having thus an anticancer role9. Vitamin E prevents 
or reduces free radical damage in diseases such as 
arthritis, cancer, cataracts and aging by preventing 
the action of free radicals on biological membranes10.
The use of antioxidant agents may represent a new 
approach to inhibiting damage caused by the excess 
of free radicals10. Mihalj et al.1 demonstrated that 
vitamin C reduces blood pressure and reestablishes 
peripheral vasodilator response in obese children. 
Weight loss is associated with a reduction in the 
production of oxidant species and a better antioxidant 
capacity, favoring a reduction in risk factors and 
an improvement in comorbidities11. Vitamin E has 
the antioxidant role of promoting the elimination 
of free radicals or stimulating the release of other 
antioxidants, as well as an important participation in 
glycemic control and prevention of complications of 
diabetes, especially in DM212.
As obesity and overweight are related to decreased 
levels of vitamins, especially those with antioxidant 
characteristics, and a redox imbalance, which in turn 
interferes with the production of TGF-β1, this study aimed 
to evaluate the influence of obesity and overweight on 
serum concentrations of vitamins C and E, TGF-β1, level 
of lipid peroxidation and cardiometabolic parameters 
in volunteers with increased body mass index (BMI) 
compared with volunteers with normal BMI.
METHODS
Study Population
Participants were recruited from January to August 
2016 in São Miguel do Oeste, Santa Catarina, southern 
Brazil. The protocol of the study was approved by 
the Ethics Committee of the University of West of 
Santa Catarina (UNOESC, no. 219.091), and all 
participants provided written informed consent. 
Experiments were performed in 169 volunteers. A total 
of 24 normal weight individuals with gender-matched 
healthy volunteers served as a control group 
(19 females and 5 males). The participants with 
increased weight were divided into two subgroups, 
matching for sex, age and BMI, and were enrolled 
as follows: 1) 16 overweight individuals (12 females 
and 4 males); 2) 129 obese young individuals 
(103 females and 26 males). The participants were 
non-smokers and were not using any medications, 
as shown in Table 1.
Table 1: Baseline characteristics of the study population.
Groups
Normal Weight Overweight Obese p
N 24 16 129
Men/Women 5/19 4/12 23/103
Age 42±15 40±19 32±12
BMI (cm) 21.7±2.1 27.9±6.0 30.1±6.4* <0.001
Weight (kg) 58.3±7.4 75.5±6.3** 103.4±22.7* <0.001
Body fat (%) 22.5±4.4 30.8±9.5** 43.5±28.8* <0.001
Body fat (kg) 13.0±2.6 25.5±18.4** 42.3±12.1* <0.001
NC (cm) 31.2±2.3 33.0±3.4 36.6±4.4* <0.001
WC (cm) 70.8±7.1 85.0±8.4 112.7±13.4* <0.001
HC (cm) 94.9±4.3 102.0±4.3 121.0±13.9* <0.001
DBP (mmHg) 10.8±1.1 12.0±5.7 13.2±1.9* <0.001
SBP (mmHg) 6.8±1.1 7.1±0.9 7.9±1.2* <0.001
Data are expressed as mean ± standard deviation or median (interquartile ranges). Data were analyzed using one-way analysis of variance 
(ANOVA), followed by Tukey’s or Kruskal-Wallis test and then by Dunn’s multiple comparison test. BMI: Body Mass Index; NC: Neck 
Circumference; WC: Waist Circumference; HC: Hip Circumference; DBP: Diastolic Blood Pressure; SBP: Systolic Blood Pressure. * p < 0.001, 
obese group compared with normal weight group. ** p < 0.001, overweight group compared with normal weight group.
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Anthropometric measurement
All measurements were performed at the 
Anthropometry Laboratory at the University of West 
of Santa Catarina, São Miguel do Oeste (Table 1). 
Standing height (H, cm) was measured to the nearest 
0.1 cm using a wall-mounted stadiometer (Charder 
model HM-210D). Weight (W, kg) was measured 
to the nearest 0.1 kg using a calibrated electronic 
scale (Toledo model 2124). BMI was calculated 
as W/H2 (kg/m2). Waist circumference (WC), neck 
circumference (NC) and hip circumference (HC) 
were measured in centimeters with a flexible tape 
to the nearest 0.1 cm. For WC the tape was applied 
above the iliac crest with the person standing with the 
abdomen relaxed, arms extended along sides and 
feet together. For NC the participant remained in the 
same position and the tape was placed around the 
neck over the hyoid bone. Body fat percentage and 
body fat mass were determined by bioimpedance 
analysis (Biodynamics Model 450). Systolic and 
diastolic pressure (SBP, DBP) were measured after 
the participant was sitting and resting for 10 minutes 
with a digital apparatus and were expressed in mmHg. 
All measurements were performed on the left side 
of the body, according to standardized procedures 
described by Lourie and Weiner13. During the 
anthropometric measurements, all participants were 
barefoot and wearing appropriate clothes.
Indices and classifications
According to the World Health Organization, 
underweight is defined as BMI < 18.5 kg/m2, normal 
weight as BMI 18.5–24.9 kg/m2, overweight as BMI 
25-29.9 kg/m2, and obesity as BMI  ≥  30 kg/m2 14, all 
without comorbidities. According to Gallagher et al.15, 
body fat percentage   ≥  20% (men) and  ≥  33% (women) 
are the cutoff points adopted to define fatness, 
corresponding to overweight classification using 
BMI in a population of young adults. According to the 
National Institute for Health and Clinical Excellence 
guidelines, WC   ≥  102 cm (men) and   ≥  88 cm 
(women) are prerequisite risk factors for the diagnosis 
of metabolic syndrome, as well as waist-to-stature 
ratio (WSR)  ≥  0.5 for both men and women16.
Laboratory methods
Blood samples were collected after 10-12-hour 
fasting by venipuncture and placed in tubes with 
ethylenediaminetetraacetic acid (EDTA) or without 
anticoagulant with separator gel to obtain the serum. 
The tubes without anticoagulant were centrifuged for 
10 minutes at 6000 rpm. The serum was separated 
and placed in amber containers to prevent metabolic 
breakdown.
Biochemical and hormonal measures
Insulin concentration was determined by 
electrochemiluminescence immunoassay using Elecsys 
2010 analyzer (Roche Diagnostics). IR index was 
calculated by homeostatic model assessment of IR 
(HOMA-IR) as follows: (fasting insulin mIU/L) × (fasting 
glucose mg/dL)/22.5. For evaluation of insulin sensitivity 
(IS), the quantitative insulin sensitivity check index 
(QUISCI) was used. Glucose, cholesterol, triglycerides 
and high-density lipoprotein cholesterol (HDL-c) 
concentrations were determined using kits (Labtest 
Diagnostics). Low-density lipoprotein cholesterol 
(LDL-c) was calculated using the Friedewald formula. 
HbA1c was measured by high performance liquid 
chromatography (HPLC) (Tosoh 2.2 Plus A1C, Tosoh 
Corporation, Tokyo, Japan), a method certified by the 
National Glycohemoglobin Standardization Program 
and standardized by the International Federation of 
Clinical Chemistry, expressed in %. Lipid peroxidation 
was estimated by measuring thiobarbituric acid 
reactive substances (TBARS) according to the 
method of Lapenna et al.17. The reaction product was 
measured spectrophotometrically at 532 nm and the 
results were expressed in nmol/L. Vitamins C and E 
were measured by enzyme-linked immunosorbent 
assay (ELISA) (ABCAM – Ascorbic Acid Assay Kit 
and Rac Beta - Tocopherol Assay Kit) and were 
expressed in nmol/μL. TGF-β1 was measured by 
ELISA (ABCAM – ab100647). This assay employs 
a specific antibody for human TGF-β1 coated on a 
96-well plate. Standards and samples are pipetted into 
the wells and TGF-β1 present in the sample is bound 
to the wells by the immobilized antibody. The wells are 
washed and biotinylated anti-human TGF-β1 antibody 
is added. After washing away unbound biotinylated 
antibody, horseradish peroxidase (HRP)-conjugated 
streptavidin is pipetted to the wells. The wells are 
washed again, a 3,3’,5,5’-tetramethylbenzidine (TMB) 
substrate solution is added to the wells and color 
develops in proportion to the amount of bound TGF-β1. 
The color of the stop solution changes from blue to 
yellow, and the intensity of the color is measured at 
450 nm and expressed in ng/mL.
Statistical Analysis
The Kolmogorov-Smirnov test was used to 
examine the distribution of variables. Comparisons 
of baseline data between the groups were performed 
using one-way analysis of variance (ANOVA) followed 
by Tukey’s test or Kruskal-Wallis test and then by 
Dunn’s multiple comparison test, in order to determine 
statistical differences between the BMI groups and 
gender. Statistical significance was defined as 
p < 0.05. The data were analyzed using Statistica 
6.0 software (StatSoft, Tulsa, OK, USA).
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RESULTS
General Characteristics Of The Study Population
Baseline characteristics of study participants are 
described in Table 1. In relation to SBP, DBP, weight, 
BMI, NC, HC, WC, body fat percentage and body fat 
mass, the obese group showed a significant increase 
(p < 0.0001) when compared with the normal weight 
and the overweight groups.
Laboratory tests
The results of laboratory tests are presented in 
Table 2 and Figures 1-4. The obese group showed 
a significant increase in insulin, glucose, HbA1c, 
HOMA-IR, cholesterol, LDL-c, triglycerides (p < 0.001), 
as well as TGF-β1, vitamin E and TBARS (p < 0.001) 
when compared with the normal weight group. In the 
obese group there was a significant reduction in IS, 
HDL-c and vitamin C (p < 0.001) when compared with 
the normal weight group. Moreover, the overweight 
group showed a significant increase (p < 0.001) in 
cholesterol, LDL-c, triglycerides, TBARS, vitamin E 
and TGF-β1, and a significant reduction (p < 0.001) 
in HDL-c and vitamin C when compared with the 
normal weight group. No significant differences 
between genders were observed.
Table 2: Biochemical concentrations of study groups.
Groups
Normal Weight Overweight Obese p
Triglycerides (mg/dL) 78.2±22.7 93.6±61.5** 137.9±84.5* <0.001
Cholesterol (mg/dL) 132 (125-163) 177 (140-225)** 182 (155-211)* <0.001
HDL-c (mg/dL) 52 (45-59) 41 (36-55)** 41 (34-48)* <0.001
LDL-c (mg/dL) 66 (52-92) 113 (87-159)** 120 (90-141)* <0.001
Glucose (mg/dL) 78±6.0 80±17 92±32* <0.001
Insulin (µUI/mL) 7.4±3.0 9.6±5.1 24.0±14.5* <0.001
HbA1c (%) 5.4±0.3 5.7±0.8 6.1±1.3* <0.001
eAG 117±4.2 127±28 132±41 0.13
HOMA-IR 1.4±0.6 1.9±1.1 5.9±5.5* <0.001
IS 0.36±0.02 0.35±0.03 0.30±0.02* <0.001
Data are expressed as mean ± standard deviation or median (interquartile ranges). Data were analyzed using one-way analysis of variance 
(ANOVA), followed by Tukey’s or Kruskal-Wallis test and then by Dunn’s multiple comparison test. HDL-c: high-density lipoprotein cholesterol; 
LDL-c: low-density lipoprotein cholesterol; HbA1c: glycated hemoglobin; eAG: estimated average glucose; HOMA-IR: homeostatic model 
assessment of insulin resistance; IS: insulin sensitivity. * p < 0.001, obese group compared with normal weight group. ** p < 0.001, overweight 
group compared with normal weight and overweight groups.
Figure 1: Serum concentration of thiobarbituric acid reactive 
substances (TBARS) in the study groups. Data are expressed 
as mean ± standard deviation. Data were analyzed using 
one-way analysis of variance (ANOVA), followed by Tukey’s 
test. *p < 0.001, obese group compared with normal weight 
group. **p < 0.001, overweight group compared with the 
normal weight and the overweight groups.
Figure 2: Serum concentration of vitamin C in the study 
groups. Data are expressed as mean ± standard deviation. 
Data were analyzed using one-way analysis of variance 
(ANOVA), followed by Tukey’s test. *p < 0.001, obese 
group compared with normal weight group. **p < 0.001, 
overweight group compared with normal weight and 
overweight groups.
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Figure 3: Serum concentration of vitamin E in the study 
groups. Data are expressed as mean ± standard deviation. 
Data were analyzed using one-way analysis of variance 
(ANOVA), followed by Tukey’s test. *p < 0.001, obese 
group compared with normal weight group. **p < 0.05, 
overweight group compared with normal weight group.
Figure 4: Serum concentration of transforming growth factor 
beta 1 (TGF-β1) in the study groups. Data are expressed 
as mean ± standard deviation. Data were analyzed using 
one-way analysis of variance (ANOVA), followed by Tukey’s 
test. *p < 0.001, obese group compared with normal 
weight group. **p < 0.001, overweight group compared 
with normal weight group.
DISCUSSION
Multiple mechanisms may contribute to the 
development of obesity-related comorbidities, including 
abnormal production of cytokines, aberrant oxidative 
stress and dysregulated proinflammatory response in 
tissues of the muscles and the liver2. Cytokines and 
inflammatory markers could mediate the facilitating 
effect of obesity on the appearance of its comorbidities 
such as IR, DM2 and cardiovascular disease18.
In the present report, we examined the influence 
of obesity and overweight on serum concentrations of 
TGF-β1, vitamins C and E, TBARS and cardiometabolic 
parameters. The results indicate that TGF-β1, 
vitamin E and TBARS are increased and vitamin 
C is decreased in obese and overweight adults 
(Figures 4, 3, 1 and 2, respectively) when compared 
with individuals with normal weight.
TGF-β1 is a type of cytokine that exhibits potent 
immunoregulatory and anti-inflammatory properties19. 
It also correlates with obesity-induced IR3, and 
TGF-β/Smad3 signaling pathway plays a key role 
in the development of IR as shown in genetically 
obese mice20. Within this context, an elevation in 
TGF-β levels may carry relevant pathophysiological 
implications. In fact, TGF-β1 potently stimulates 
monocyte chemotaxis and endothelial transmigration 
and promotes smooth muscle cell proliferation and 
migration by up-regulating platelet-derived growth 
factor gene expression21. These represent early 
events in atherosclerosis development. TGF-β1 also 
induces PAI-1 both in live and cultured adipocytes22, 
as well as in other tissues23. In addition, together with 
increased BMI, there was greater serum accumulation 
of triglycerides, total cholesterol and especially LDL-c, 
suggesting that the elevated secretion of TGF-β1 in 
obese conditions may affect lipid metabolism in obese 
and overweight adults, triggering the production of 
LDL-c in liver cells and degrading the LDL-c receptor 
in the liver. Furthermore, this cytokine has atherogenic 
potential by increasing the expression of intercellular 
adhesion molecule-1 and anti-vascular-1 in vascular 
endothelial cells and increasing nuclear factor kappa 
beta (NF-kβ) activity, a flare gun for induction of these 
adhesion molecules24.
It has been shown that TGF-β/Smad3 signaling is 
an important regulator of insulin gene transcription and 
β-cell function, and TGF-β signaling represses insulin 
gene transcription25. Also, TGF-β signaling regulates 
glucose tolerance26. In fact, concomitantly with the 
increase in TGF-β1 in proportion to the increase in 
BMI, we observed a significant increase in insulin, 
glucose, HbA1c and HOMA-IR levels and a significant 
decrease in IS, suggesting that this cytokine could 
play an important role in the development of IR in 
patients with excess weight. Previous studies have 
shown that TGF-β contributes to the development 
of IR in pregnant women27-29.
Another relevant point is that TGF-β1 increases 
the production of ROS by impairing mitochondrial 
function and inducing NOXs, especially NOX4, a 
non-phagocytic NOX expressed by many different 
types of cells. TGF-β also suppresses the antioxidant 
system, including the synthesis of glutathione, the 
most abundant intracellular free thiol and an important 
antioxidant, and several other antioxidant enzymes, 
leading to oxidative stress or redox imbalance. 
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